Starting from the observation that LONP1 expression closely correlates with adverse clinicopathological features and poor prognosis in patients with PCa, our study here underscored that the elevated LONP1 expression promotes tumor progression and metastasis both in vitro and in vivo. The gene discussed is LONP1; the disease is neoplasm.